Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial

Frontiers in Oncology
Anita J W M BrounsAnne-Marie C Dingemans

Abstract

Introduction: Approximately 80% of non-small cell lung cancer (NSCLC) patients with bone metastases have cancer induced bone pain (CIBP). Methods: The NVALT-9 was an open-label, single arm, phase II, multicenter study. Main inclusion criterion: bone metastasized NSCLC patients with uncontrolled CIBP [brief pain inventory [BPI] ≥ 5 over last 7 days]. Patients were treated with six milligram ibandronate intravenously (day 1-3) once a day. Main exclusion criteria: active secondary malignancy, systemic anti-tumor treatment and radiotherapy ≤4 weeks before study start, previous bisphosphonate treatment. Statistics: Simon's Optimal two-stage design with a 90% power to declare the treatment active if the pain response rate is ≥ 80% and 95% confidence to declare the treatment inactive if the pain response rate is ≤ 60%. If pain response is observed in ≤ 12 of the first 19 patients further enrollment will be stopped. Primary endpoint: bone pain response, defined as 25% decrease in worst pain score (PSc) over a 3-day period (day 5-7) compared to baseline PSc with maximum of 25% increase in mean analgesic consumption during the same period. Secondary endpoints: BPI score, quality of life, toxicity and World Health Organization Performance...Continue Reading

References

Dec 24, 2002·Prostate Cancer and Prostatic Diseases·A HeidenreichR Hofmann
Jul 26, 2003·BMJ : British Medical Journal·Paul GlareNicholas Christakis
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Isabelle ManciniJean-Jacques Body
Sep 1, 2005·The Lancet Oncology·Mellar P DavisSusan B LeGrand
Apr 25, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Asuka TsuyaMasahiro Fukuoka
Sep 30, 2010·Psycho-oncology·Steven C H KaoJanette Vardy
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Matthew H F WongNick Pavlakis
Sep 8, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Maria A Lopez-OlivoMaria E Suarez-Almazor
Feb 18, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·L E L HendriksA-M C Dingemans
May 2, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ColemanUNKNOWN ESMO Guidelines Working Group
Jul 1, 2014·Journal of Pain and Symptom Management·Julia RileyJoy Ross
Aug 15, 2014·Journal of Oncology Practice·Raymond W JangCamilla Zimmermann
Dec 23, 2015·Scientific Reports·Daniele SantiniTonini Giuseppe
Jan 1, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lizza E L HendriksAnne-Marie C Dingemans
Dec 1, 2017·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Srinivas RamanMichael Brundage
Jul 15, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·David S EttingerMiranda Hughes
Oct 26, 2018·British Journal of Clinical Pharmacology·Patrick W Mantyh
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D PlanchardUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Citations

Mar 2, 2021·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lizza E L HendriksEgbert F Smit

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seminars in Oncology
Axel HeidenreichJean-Jacques Body
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
B LairdM Fallon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Isabelle ManciniJean-Jacques Body
© 2021 Meta ULC. All rights reserved